Analyst downgrades typically lead to a negative short-term impact on the stock price as they suggest a less favorable outlook on the company's future performance. The downgrade from Buy to Neutral by a reputable analyst suggests a significant change in the perceived investment potential of Cue Health, likely leading to decreased investor confidence and a potential drop in stock price.